Daewoong pharmaceutical Co.,Ltd (069620.KS)
KRW 143800.0
(4.2%)
KRW 143800.0
(4.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 93.41 Billion KRW | -55.91% |
| 2022 | 211.85 Billion KRW | 12.26% |
| 2021 | 188.72 Billion KRW | -36.61% |
| 2020 | 297.72 Billion KRW | 1.75% |
| 2019 | 292.6 Billion KRW | 63.02% |
| 2018 | 179.48 Billion KRW | -37.97% |
| 2017 | 289.33 Billion KRW | 0.06% |
| 2016 | 289.16 Billion KRW | 52.67% |
| 2015 | 189.41 Billion KRW | 35.77% |
| 2014 | 139.51 Billion KRW | 249.95% |
| 2013 | 39.86 Billion KRW | 0.0% |
| 2012 | - KRW | 0.0% |
| 2011 | - KRW | -100.0% |
| 2010 | 29.93 Billion KRW | -42.97% |
| 2009 | 52.48 Billion KRW | -46.71% |
| 2008 | 98.5 Billion KRW | 232.73% |
| 2007 | 29.6 Billion KRW | 0.0% |
| 2006 | - KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 93.41 Billion KRW | 0.0% |
| 2024 Q2 | 259.25 Billion KRW | 177.53% |
| 2023 Q4 | 93.41 Billion KRW | 78.5% |
| 2023 FY | 93.41 Billion KRW | -55.91% |
| 2023 Q2 | 142.38 Billion KRW | -31.4% |
| 2023 Q1 | 207.56 Billion KRW | -2.03% |
| 2023 Q3 | 52.33 Billion KRW | -63.24% |
| 2022 FY | 211.85 Billion KRW | 12.26% |
| 2022 Q3 | 253.74 Billion KRW | 0.01% |
| 2022 Q4 | 211.85 Billion KRW | -16.51% |
| 2022 Q2 | 253.73 Billion KRW | 34.5% |
| 2022 Q1 | 188.65 Billion KRW | -0.04% |
| 2021 Q2 | 198.89 Billion KRW | -33.23% |
| 2021 FY | 188.72 Billion KRW | -36.61% |
| 2021 Q1 | 297.89 Billion KRW | 0.06% |
| 2021 Q3 | 288.68 Billion KRW | 45.15% |
| 2021 Q4 | 188.72 Billion KRW | -34.63% |
| 2020 Q2 | 294.16 Billion KRW | -0.0% |
| 2020 Q1 | 294.17 Billion KRW | 0.54% |
| 2020 FY | 297.72 Billion KRW | 1.75% |
| 2020 Q3 | 208.91 Billion KRW | -28.98% |
| 2020 Q4 | 297.72 Billion KRW | 42.51% |
| 2019 Q2 | 282.6 Billion KRW | 56.45% |
| 2019 FY | 292.6 Billion KRW | 63.02% |
| 2019 Q1 | 180.63 Billion KRW | 0.64% |
| 2019 Q4 | 292.6 Billion KRW | 3.57% |
| 2019 Q3 | 282.52 Billion KRW | -0.03% |
| 2018 Q3 | 279.31 Billion KRW | 47.29% |
| 2018 Q1 | 289.42 Billion KRW | 0.03% |
| 2018 FY | 179.48 Billion KRW | -37.97% |
| 2018 Q4 | 179.48 Billion KRW | -35.74% |
| 2018 Q2 | 189.63 Billion KRW | -34.48% |
| 2017 Q4 | 289.33 Billion KRW | 45.0% |
| 2017 FY | 289.33 Billion KRW | 0.06% |
| 2017 Q3 | 199.54 Billion KRW | -31.04% |
| 2017 Q2 | 289.35 Billion KRW | 0.03% |
| 2017 Q1 | 289.25 Billion KRW | 0.03% |
| 2016 Q4 | 289.16 Billion KRW | -0.03% |
| 2016 Q1 | 189.47 Billion KRW | 0.04% |
| 2016 Q2 | 289.14 Billion KRW | 52.6% |
| 2016 FY | 289.16 Billion KRW | 52.67% |
| 2016 Q3 | 289.24 Billion KRW | 0.04% |
| 2015 FY | 189.41 Billion KRW | 35.77% |
| 2015 Q2 | 139.6 Billion KRW | 0.03% |
| 2015 Q3 | 229.29 Billion KRW | 64.24% |
| 2015 Q1 | 139.55 Billion KRW | 0.03% |
| 2015 Q4 | 189.41 Billion KRW | -17.39% |
| 2014 Q2 | 39.88 Billion KRW | 0.03% |
| 2014 Q3 | 39.9 Billion KRW | 0.03% |
| 2014 FY | 139.51 Billion KRW | 249.95% |
| 2014 Q4 | 139.51 Billion KRW | 249.64% |
| 2014 Q1 | 39.87 Billion KRW | 0.03% |
| 2013 FY | 39.86 Billion KRW | 0.0% |
| 2013 Q3 | - KRW | 0.0% |
| 2013 Q2 | - KRW | 0.0% |
| 2013 Q4 | 39.86 Billion KRW | 0.0% |
| 2013 Q1 | - KRW | 0.0% |
| 2012 Q1 | - KRW | 0.0% |
| 2012 Q4 | - KRW | 0.0% |
| 2012 FY | - KRW | 0.0% |
| 2011 Q1 | - KRW | 0.0% |
| 2011 FY | - KRW | -100.0% |
| 2011 Q3 | - KRW | 0.0% |
| 2011 Q2 | - KRW | 0.0% |
| 2010 Q1 | 52.48 Billion KRW | -40.46% |
| 2010 FY | 29.93 Billion KRW | -42.97% |
| 2010 Q2 | 48.49 Billion KRW | -7.61% |
| 2010 Q3 | 29.92 Billion KRW | -38.29% |
| 2009 Q2 | 93.93 Billion KRW | 0.0% |
| 2009 Q4 | 88.14 Billion KRW | -1.15% |
| 2009 Q3 | 89.17 Billion KRW | -5.07% |
| 2009 FY | 52.48 Billion KRW | -46.71% |
| 2008 Q3 | 59.17 Billion KRW | 89.89% |
| 2008 Q2 | 31.16 Billion KRW | 0.0% |
| 2008 Q4 | 62.66 Billion KRW | 5.89% |
| 2008 FY | 98.5 Billion KRW | 232.73% |
| 2007 FY | 29.6 Billion KRW | 0.0% |
| 2007 Q2 | - KRW | 0.0% |
| 2007 Q4 | - KRW | 0.0% |
| 2007 Q3 | - KRW | 0.0% |
| 2006 FY | - KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Dongwha Pharm.Co.,Ltd | 16.12 Billion KRW | -479.224% |
| Yuhan Corporation | 60.23 Billion KRW | -55.088% |
| Yuhan Corporation | 60.23 Billion KRW | -55.088% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -584.861% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -584.861% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -584.861% |
| Ildong Holdings Co., Ltd. | 29.87 Billion KRW | -212.671% |
| Samil Pharmaceutical Co.,Ltd | 49.56 Billion KRW | -88.457% |
| Dong-A Socio Holdings Co., Ltd. | 202.06 Billion KRW | 53.769% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -211.385% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -211.385% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -211.385% |
| SAMSUNG PHARM. Co., LTD. | 101.81 Million KRW | -91647.631% |
| Chong Kun Dang Holdings Corp. | 72.11 Billion KRW | -29.541% |
| Dong Sung Bio Pharm.Co.,Ltd. | 18.52 Billion KRW | -404.337% |
| HANDOK Inc. | 123.78 Billion KRW | 24.531% |
| Jeil Pharma Holdings Inc | 10.5 Billion KRW | -789.671% |
| Kukje Pharma Co., Ltd. | 475.74 Million KRW | -19535.696% |
| Bukwang Pharmaceutical Co., Ltd. | 78.52 Billion KRW | -18.962% |
| Aprogen pharmaceuticals,Inc. | 32 Billion KRW | -191.923% |
| Ilsung Pharmaceuticals Co., Ltd. | 119.67 Million KRW | -77955.363% |
| Daewon Pharmaceutical Co., Ltd. | 34.57 Billion KRW | -170.184% |
| Yungjin Pharm. Co., Ltd. | 40.37 Billion KRW | -131.353% |
| Boryung Corporation | 151.7 Billion KRW | 38.424% |
| Hyundai Pharmaceutical Co., Ltd. | 580.64 Million KRW | -15988.183% |
| Samjin Pharmaceuticals Co., Ltd. | 4.16 Billion KRW | -2141.984% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -1444.056% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -1444.056% |
| Suheung Co., Ltd. | 74 Billion KRW | -26.225% |
| Kwang Dong Pharmaceutical Co., Ltd. | 19.02 Billion KRW | -390.945% |
| Hanall Biopharma Co.,Ltd | 590.3 Million KRW | -15724.827% |
| Whan In Pharm Co.,Ltd. | 307.05 Million KRW | -30322.901% |
| MYUNGMOON Pharm co.,Ltd | 12.58 Billion KRW | -642.323% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -42563.036% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -42563.036% |
| Korea United Pharm Inc. | 10.96 Billion KRW | -752.136% |
| CKD Bio Corp. | 69.43 Billion KRW | -34.544% |
| JW Holdings Corporation | 20.65 Billion KRW | -352.214% |
| REYON Pharmaceutical Co., Ltd. | 121 Billion KRW | 22.797% |
| Hanmi Pharm. Co., Ltd. | 82.02 Billion KRW | -13.882% |
| Dong-A ST Co., Ltd. | 161.99 Billion KRW | 42.333% |
| Chong Kun Dang Pharmaceutical Corp. | 30 Billion KRW | -211.385% |
| JW Lifescience Corporation | 168 Million KRW | -55504.411% |
| Ildong Pharmaceutical Co., Ltd. | 14.82 Billion KRW | -530.113% |
| Jeil Pharmaceutical Co.,Ltd | 4.45 Billion KRW | -1998.278% |
| Hana Pharm Co., Ltd. | 1.59 Billion KRW | -5742.678% |